These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies. Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596 [TBL] [Abstract][Full Text] [Related]
9. Adverse effects of risperidone and haloperidol treatment in schizophrenia. Yen YC; Lung FW; Chong MY Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):285-90. PubMed ID: 14751424 [TBL] [Abstract][Full Text] [Related]
10. Symptom change and extrapyramidal side effects during acute haloperidol treatment in chronic geriatric schizophrenics. Weisbard JJ; Pardo M; Pollack S Psychopharmacol Bull; 1997; 33(1):119-22. PubMed ID: 9133762 [TBL] [Abstract][Full Text] [Related]
11. Blood levels of haloperidol in schizophrenic patients. Shvartsburd A; Dekirmenjian H; Smith RC J Clin Psychopharmacol; 1983 Feb; 3(1):7-12. PubMed ID: 6833528 [TBL] [Abstract][Full Text] [Related]
12. [Use of very high doses of haloperidol in the treatment of acute psychotic episodes. Clinical and pharmacokinetic analysis apropos of 15 cases]. Petit P; Blayac JP; Castelnau D; Billet J; Puech R; Pouget R Encephale; 1987; 13(3):127-30. PubMed ID: 3595515 [TBL] [Abstract][Full Text] [Related]
13. Haloperidol plasma and red blood cell levels and clinical antipsychotic response. Garver DL; Hirschowitz J; Glicksteen GA; Kanter DR; Mavroidis ML J Clin Psychopharmacol; 1984 Jun; 4(3):133-7. PubMed ID: 6736272 [TBL] [Abstract][Full Text] [Related]
15. Relation of plasma and red blood cells reduced haloperidol concentrations to haloperidol reductase activity assayed in red blood cells in psychiatric population. Shibasaki M; Someya T; Takahashi S Prog Neuropsychopharmacol Biol Psychiatry; 1993 Mar; 17(2):257-67. PubMed ID: 8430218 [TBL] [Abstract][Full Text] [Related]
16. The impact of the CYP2D6 polymorphism on haloperidol pharmacokinetics and on the outcome of haloperidol treatment. Brockmöller J; Kirchheiner J; Schmider J; Walter S; Sachse C; Müller-Oerlinghausen B; Roots I Clin Pharmacol Ther; 2002 Oct; 72(4):438-52. PubMed ID: 12386646 [TBL] [Abstract][Full Text] [Related]
17. Plasma concentrations of timiperone and its reduced metabolite in the patients on timiperone. Shimoda K; Someya T; Morita S; Hirokane G; Yokono A; Shibasaki M; Takahashi S Psychiatry Clin Neurosci; 1998 Oct; 52(5):535-40. PubMed ID: 10215017 [TBL] [Abstract][Full Text] [Related]
18. Striatal dopaminergic D2 receptor occupancy and clinical efficacy in psychosis exacerbation: a 123I-IBZM study with ziprasidone and haloperidol. Corripio I; Catafau AM; Perez V; Puigdemont D; Mena E; Aguilar Y; Carrió I; Alvarez E Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):91-6. PubMed ID: 15610950 [TBL] [Abstract][Full Text] [Related]
19. A double blind comparison of zuclopenthixol acetate with haloperidol in the management of acutely disturbed schizophrenics. Chin CN; Hamid AR; Philip G; Ramlee T; Mahmud M; Zulkifli G; Loh CC; Zakariah MS; Norhamidah MS; Suraya Y; Roslan KA; Chandramohan P; Cheah YC; Leonard AO Med J Malaysia; 1998 Dec; 53(4):365-71. PubMed ID: 10971979 [TBL] [Abstract][Full Text] [Related]
20. [Pharmaco-clinical correlations during fluoxetine administration in patients with depressive schizophrenia treated with haloperidol decanoate]. Viala A; Aymard N; Leyris A; Caroli F Therapie; 1996; 51(1):19-25. PubMed ID: 8762216 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]